R&D
GSK Wins First-Ever Approval for a Hepatitis B ‘Functional Cure’ in Japan
Hibsago (bepirovirsen) becomes the first therapy cleared anywhere aimed at functionally curing chronic hepatitis B — a milestone in a disease that infects hundreds of millions worldwide.